Meet Proteona at Phar-East: Singapore, 20 Mar. 2019

Meet Proteona at Phar-East in Singapore Hu Chen from Unsplash

Meet the Proteona team at the Phar-East Conference in Singapore

Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications

Proteona announced that Dr Andreas Schmidt, Proteona Chief Executive Officer, will present at the Phar-East conference in Singapore at 14:40pm on the 20th March, 2019.

Dr Schmidt will share on the latest updates on Proteona and will be available during the conference for discussions.

Event details

Schedule a meeting

For media queries, please contact:

Dr Andreas Schmidt

About Proteona

Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services.